BONSTEIN SARA (Chief Financial Officer) sold 5.5% of their position (4.64K shares) of INSMED INC on the open market
Open‑market sale worth $808.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/8/2026ACC: 0001604019-26-000004
Officer· Chief Financial Officer
Since Jan 2020
-4.64K
Net shares
Net seller
$808.7K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
4.64K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.52K
Price / share
$173.33
Trade value
$262.94K
% of position
1.8%
1/6/2026
85.15K→83.63K
Common Stock
Direct
Shares
−1.68K
Price / share
$175.07
Trade value
$293.77K
% of position
2.0%
1/7/2026
83.63K→81.95K
Common Stock
Direct
Shares
−1.45K
Price / share
$174.17
Trade value
$252.02K
% of position
1.8%
1/8/2026
81.95K→80.51K
Total
Net shares
−4.64K
Net value
-$808.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2026 | S · Sale | −1.52K | $173.33 | $262.94K | 1.8% | 85.15K | 83.63K |
| Common Stock Direct | 1/7/2026 | S · Sale | −1.68K | $175.07 | $293.77K | 2.0% | 83.63K | 81.95K |
| Common Stock Direct | 1/8/2026 | S · Sale | −1.45K | $174.17 | $252.02K | 1.8% | 81.95K | 80.51K |
| Total | −4.64K | -$808.73K | ||||||
Derivative Transactions0
No derivative transactions reported